Inga Prokopenko is an e-One Health Professor and Director of the Multi-Omics Statistics Department at the University of Surrey, Associate Researcher at the University of Lille, and is in charge of the “studies of links between diabetes and cancer risks” project within the Center National PreciDIAB. After her BSc/MSc in Biology and Chemistry, with a specialization in Human Genetics, her first junior-lead graduate research experience came from a large-scale study on the causes of birth defects and infertile marriages in Ukraine, and, later, during an international genetic epidemiology and molecular genetics MSc and PhD in Pavia, Italy. Then, she worked at the GlaxoSmithKline R&D, the Psychiatry Translational Medicine & Genetics. She then moved to a Post-Doctoral Position at the WTCHG/OCDEM, University of Oxford, UK, to focus on large-scale studies investigating genetic susceptibility to type 2 diabetes (T2D). Later, she became a Senior Lecturer, which was followed by a Reader Position in Human Genomics at the Department of Genomics of Common Diseases, Imperial College London, UK. Since 2019, she has been a Professor in eOne Health at the University of Surrey, Vice-Chancellor’s Distinguished Chair, and Head of the Section of Statistical Multi-Omics, as well as a Visiting Professor within PreciDIAB at the University of Lille, France. Since August 2021, she is also a Co-Director of the People-Centered AI Institute at the University of Surrey.